You are here: Industry Insights > Torrent

News List

Cipla, Dr Reddy’s, Emcure, Sun Pharma and Torrent to partner for clinical trial of Molnupiravir expresspharma
June 30, 2021
As per the directive of the SEC of the CDSCO, Dr Reddy’s will conduct the clinical trial and the other four pharma companies will be required to demonstrate equivalence of their product to the product used by Dr Reddy’s in its clinical trial.
Lilly signs licensing agreements with Dr Reddy’s, MSN Labs and Torrent Pharma for Baricitinib expresspharma
May 14, 2021
On May 10, Lilly had also announced the signing of three Voluntary License Agreements with Cipla, Lupin and Sun Pharma Industries.
Four pharma majors invest in ABCD Technologies expresspharma
March 26, 2021
Drug majors Sun Pharma, Lupin, Cadila Healthcare and Torrent Pharma on Thursday said they have subscribed to partnership interest in healthcare services firm ABCD Technologies which will be renamed as IndoHealth Services.
Torrent Recalls Anagrelide Capsules, USP Due to Dissolution Test Failure americanpharmaceuticalreview
December 11, 2020
Torrent Pharmaceuticals is voluntarily recalling one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing.
Torrent recall, Dr Reddy's distribution halt add to cracks in global drug supply chain fiercepharma
September 26, 2019
With further testing, scientists found that two other impurities, NMBA and N-Nitrosodiethylamine, were also being created in some situations.
More Blood Pressure Drugs Recalled drugs
September 25, 2019
The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots.
FDA finds testing issues at Torrent plant fiercepharma
May 14, 2019
Torrent had to recall 2.2 million bottles of losartan blood pressure drugs that were made with an API from Hetero Labs that was discovered to be tainted with impurities that are considered cancer causing. (Torrent Pharmaceuticals)
Torrent recalls more than 1M bottles of tainted blood pressure meds fiercepharma
April 23, 2019
The recall from the U.S. of tainted blood pressure medicines reached new heights as India’s Torrent Pharmaceuticals recalled 104 lots of losartan over the weekend because they contained an impurity suspected of causing cancer.
Torrent Expands its Voluntary Recall of Losartan americanpharmaceuticalreview
January 24, 2019
Torrent Pharmaceuticals is further expanding its voluntary recall to include six additional lots of losartan potassium and hydrochlorothiazide combination tablets, for a total of 16 lots of losartan-containing medicines....
Torrent Pharma in agreement with Unichem expressbpd
November 06, 2017
Torrent Pharmaceuticals has entered into a definitive binding agreement with Unichem to acquire its branded business of India and Nepal for a consideration of Rs 3600 crore.

Previous page 1 2 Next page